WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Results 1-10 of 364 for Criteria: Office(s):all Language:EN Stemming: true maximize
Filters CTR:PCT close
prev 1 2 3 4 5 6 7 8 9 10 next
Page: / 37  Go >
RSS iconmap icon 

Analysis
Analysis

List Length
Machine translation
TitleCtrPubDate
Int.ClassAppl.NoApplicantInventor
1. WO/2015/044876 MOLECULAR WEIGHT MARKERS FOR PROTECTED POLYPEPTIDESWO02.04.2015
C08F 210/00
PCT/IB2014/064797DR. REDDY'S LABORATORIES LIMITEDKATKAM, Srinivas
The present invention provides trifluoroacetyl copolymers useful as standard molecular weight markers in the intermediary stage for obtaining glatiramer acetate having desired average molecular weight. The present invention further provides a process for determining the average molecular weight of glatiramer acetate or other copolymers using molecular weight markers of protected polypeptides.

2. WO/2015/026737 SELECTABLE SINGLE DOSE AUTO-INJECTOR AND METHODS OF MAKING AND USING SAMEWO26.02.2015
A61M 5/20
PCT/US2014/051531DR. REDDY'S LABORATORIES, LTD.KUMAR, Rajesh
An auto-injector device for administering a liquid pharmaceutical composition, in which an end-user can select between doses that the device is capable of delivering. The end-user choices that translate into the selected doses can be based on end-user perceived severity of symptoms, end-user weight and other such factors. In some embodiments the auto-injector is configured to administer the one chosen dose only. In other embodiments, the auto-injector can deliver second and subsequent doses up to full dose of the pharmaceutical composition disposed in the injector. The auto-injector can provide visual, audio, and tactile feedback, alone or in combination, to the user to indicate the dose selected, instructions for use, and when the dose has been administered.

3. WO/2014/188353 PROCESSES FOR THE PREPARATION OF DEHYDROEPIANDROSTERONE AND ITS INTERMEDIATESWO27.11.2014
C07J 75/00
PCT/IB2014/061590DR. REDDY'S LABORATORIES LIMITEDFRYSZKOWSKA, Anna
The present application relates to a regioselective and stereoselective processes for the preparation of dehydroepiandrosterone (DHEA) and processes for its intermediates.

4. WO/2014/170866 PROCESS OF OBTAINING GLYCOPROTEIN COMPOSITION WITH INCREASED GALACTOSYLATION CONTENTWO23.10.2014
C07K 14/435
PCT/IB2014/060812DR. REDDY'S LABORATORIES LIMITEDTHUDUPPATHY, Guruvasuthevan Ramasamy
A cell culture process for production of glycoprotein composition with increased galactosylation content while maintaining specific productivity is provided. The process involves culturing cells at high pCO 2 and subjecting cells to temperature downshift to obtain a glycoprotein with specific glycoprotein composition.

5. WO/2014/155349 REFOLDING OF PROTEINSWO02.10.2014
C07K 1/36
PCT/IB2014/060251DR. REDDY'S LABORATORIESPARAYITAM, Bharata, Ratnam
Provided is a method of refolding of recombinant GCSF that minimizes the generation of oxidized forms of GCSF by optimizing the refolding of inclusion bodies containing recombinant GCSF.

6. WO/2014/145710 PARENTERAL DICLOFENAC COMPOSITIONWO18.09.2014
A61K 47/24
PCT/US2014/030519DR. REDDY'S LABORATORIES, LTD.OKUMU, Franklin
The present application provides parenteral compositions of diclofenac or its pharmaceutically acceptable salt and methods for making and using such compositions. Some of the compositions of the present application has one or more following properties: (1) ready to be injectable, (2) in the form of an oil-in-water emulsion, (3) stable under appropriate storage conditions, (4) containing therapeutically effective amount of diclofenac or its pharmaceutically acceptable salt, (5) sterilizable by filtration (6) containing components acceptable by regulatory agencies (e.g. the FDA), (7) containing low oil content and thus not exacerbating hyerlipidemia, and (8) is neither hyperallergenic nor vein irritating.

7. WO/2014/128564 PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORSWO28.08.2014
A61K 9/16
PCT/IB2014/000715DR. REDDY'S LABORATORIES LTD.NEKKANTI, Vijay, Kumar
The present application discloses a pharmaceutical composition comprising a class of cholesteryl ester transfer protein (CETP) inhibitors with improved oral bioavailability. The application further discloses compositions comprising a class of CETP inhibitor and at least one surfactant in the form of a solution, suspension, emulsion or a pre-concentrate.

8. WO/2014/118685 METHOD OF ALTERING THE ACIDIC VARIANT CONTENT OF ANTIBODYWO07.08.2014
C07K 1/18
PCT/IB2014/058553DR. REDDY'S LABORATORIES LIMITEDKULKARNI, Samir, R.
A method of altering the amount of acidic variants in antibody composition, in particular, employs a cation exchange chromatography with varying amounts of wash buffer column volume to alter the acidic variant content of the antibody.

9. WO/2014/083512 PROCESS FOR PREPARATION OF ABIRATERONE ACETATEWO05.06.2014
C07J 43/00
PCT/IB2013/060441DR. REDDY'S LABORATORIES LIMITEDDAHANUKAR, Vilas Hareshwar
The present invention relates to process for the preparation of abiraterone acetate, its salts and intermediates thereof, crystalline forms of abiraterone acetate salts and purification of abiraterone acetate.

10. WO/2014/076568 PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORSWO22.05.2014
A61K 9/16
PCT/IB2013/002909DR. REDDY'S LABORATORIES LTD.PADHI, Bijay, Kumar
The present application discloses a pharmaceutical composition comprising a class of CETP inhibitors with improved oral bioavailability. The application further discloses compositions comprising a class of CETP inhibitor and at least one solubility improving material and optionally one or more wetting agents.


Results 1-10 of 364 for Criteria: Office(s):all Language:EN Stemming: true
prev 1 2 3 4 5 6 7 8 9 10 next